You have identified the mutation in a p53 gene responsible f…

You have identified the mutation in a p53 gene responsible for an aggressive type of lung cancer. The mutation is highlighted in red and underlined in the DNA template strand data below. What type of mutation is it? [blank1] What change does the mutation cause? [blank2] Normal p53 Sequence: AATGCACAACCATTGCCAMutant p53 Sequence: AATGCACCACCATTGCCA

Most traits are quantitative, meaning they exhibit continuou…

Most traits are quantitative, meaning they exhibit continuous variation in a population. This is exemplified in the graph below for beak width in a population of finches. Continuous variation in a trait like beak width suggests that the trait is determined by…

In the spring of 2020, CRISPR-Cas9 was used in a pilot study…

In the spring of 2020, CRISPR-Cas9 was used in a pilot study to see if it could be used to eliminate blindness in people with Leber’s congenital amaurosis 10 (LCA10). In this trial experiment, patients had targeted CRISPR-Cas9 injected underneath their retinas, where it would hopefully edit a mutation in the CEP290 gene that is responsible for the condition. Genetic technology used to treat a disease in an individual is known as ________.

You have identified the mutation in a p53 gene responsible f…

You have identified the mutation in a p53 gene responsible for an aggressive type of lung cancer. The mutation is highlighted in red and underlined in the DNA template strand data below. What type of mutation is it? [blank1] What change does the mutation cause? [blank2] Normal p53 Sequence: AATGCAACCCCATTGMutant p53 Sequence: AATGCAATCCCATTG

In a clinical trial for hemophilia B, a bleeding disorder ca…

In a clinical trial for hemophilia B, a bleeding disorder caused by mutations in the gene for clotting factor IX, researchers evaluated an AAV-vector gene therapy delivering a functional factor IX gene. Three cohort groups received a single intravenous infusion at different doses (low, medium, and high), while a fourth cohort received a placebo infusion. After one year, researchers measured factor IX activity in the blood and recorded the number of bleeding episodes for each participant. What is the independent variable in this experiment?